- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Artemisia Annua Extract
Catalog No. | HE0018 |
---|---|
Purity | 99% Artemisinin HPLC |
Package | 25 kg/drum |
Botanical Source | Artemisia Annua |
Appearance | Powder |
Storage | Stored in cool and dry places, protected from direct sunlight and heat. |
Shelf Life | 2 years |
Safety Tips of Artemisia Annua Extract
Handling of artemisia annua extract should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Products
-
Catalog No.: PI0017
CAS No.: 88495-63-0
Molecular Weight: 384.43
Purity: 97% HPLC
Package: 25 kg/drum
-
Catalog No.: PI0047
CAS No.: 27200-12-0
Molecular Weight: 320.25
Purity: 98% HPLC
Package: 25 kg/drum
Related Applications
Antioxidant Supplements
Antioxidants are one kind of molecules, helping to neutralize harmful free radicals which can accelerate cellular oxidation. They provide an important and solid defense against the diseases caused by oxidative stress, such as cancer, heart disease, decline in brain function, immune system and aging. Because antioxidants are capable of stabilizing or deactivating the free radicals from oxidation reactions before they attack cells.
Related Researches
- 1. The metabolite chemotype of Nicotiana benthamiana transiently expressing artemisinin biosynthetic pathway genes is a function of CYP71AV1 type and relative gene dosage.
Ting HM, et al. New Phytol 2013 May 2.
- 2. Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.
Wei M, et al. Immunopharmacol Immunotoxicol 2013 May 1.
- 3. The Use of Combining Ability Analysis to Identify Elite Parents for Artemisia annua F1 Hybrid Production.
Townsend T, et al. PLoS One 2013 Apr 23;8(4):e61989.
- 4. Toxic essential oils. Part II: Chemical, toxicological, pharmacological and microbiological profiles of Artemisia annua L. volatiles.
Radulovi? NS, et al. Food Chem Toxicol 2013 Apr 20.
- 5. Quantitative Structure-Activity Relationships of the Antimalarial Agent Artemisinin and some of its Derivatives - A DFT Approach.
Rajkhowa S, et al. Comb Chem High Throughput Screen 2013 Apr 10.
- 6. High-level semi-synthetic production of the potent antimalarial artemisinin.
Paddon CJ, et al. Nature 2013 Apr 25;496(7446):528-32.
- 7. Differentially Expressed Genes during Contrasting Growth Stages of Artemisia annua for Artemisinin Content.
Nair P, et al. PLoS One 2013;8(4):e60375.
- 8. Proteomics Analysis of Hepatoprotective Effects for Scoparone Using MALDI-TOF/TOF Mass Spectrometry with Bioinformatics.
Zhang A, et al. OMICS 2013 Apr;17(4):224-9.
- 9. Is Artemisinin the Only Antiplasmodial Compound in the Artemisia annua Tea Infusion? An in Vitro Study.
Mouton J, et al. Planta Med 2013 Apr;79(6):468-70.
- 10. Indole-3-Acetic Acid Production by Endophytic Streptomyces sp. En-1 Isolated from Medicinal Plants.
Lin L, et al. Curr Microbiol 2013 Mar 20.